Welcome to
RBP World!
Drugs target to RPTOR
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| INDOXIMOD | Small molecule | ependymoma | mTORC1 activator | 1.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | metastatic melanoma | mTORC1 activator | 1.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | non-small cell lung carcinoma | mTORC1 activator | 1.0 | Terminated | ClinicalTrials |
| INDOXIMOD | Small molecule | acute myeloid leukemia | mTORC1 activator | 1.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | breast cancer | mTORC1 activator | 2.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | neoplasm | mTORC1 activator | 1.0 | Withdrawn | ClinicalTrials |
| INDOXIMOD | Small molecule | gliosarcoma | mTORC1 activator | 1.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | pancreatic adenocarcinoma | mTORC1 activator | 1.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | metastatic prostate cancer | mTORC1 activator | 2.0 | Completed | ClinicalTrials |
| INDOXIMOD | Small molecule | melanoma | mTORC1 activator | 2.0 | Terminated | ClinicalTrials |
| INDOXIMOD | Small molecule | medulloblastoma | mTORC1 activator | 1.0 | Completed | ClinicalTrials |